Metabolomics is the study of small compounds, often known as metabolites, in cells, biofluids, tissues, and organisms on a massive scale. The metabolome refers to the collection of tiny molecules and their interactions inside a biological system. Metabolomics is a strong method because, unlike other "omics" metrics, metabolites and their concentrations directly represent the underlying biochemical activity and condition of cells and tissues. As a result, metabolomics is the best representation of the molecular phenotype. The metabolome refers to the entire set of small-molecule (1.5 kDa) metabolites identified in a biological sample, such as a single organism (metabolic intermediates, hormones and other signalling molecules, and secondary metabolites). The term was coined in the same way as transcriptomics and proteomics were coined; the metabolome, like the transcriptome and proteome, is dynamic, changing from second to second. Despite the ease with which the metabolome may be described, it is currently not possible to analyse the whole range of metabolites using a single analytical approach.
Metabonomics is being combined with genomics and proteomics to form a new systems biology that takes into account the complex interrelationships between the genome, proteome, and metabolome. Metabonomics is a subset of metabolomics, defined as the quantitative measurement of multiparametric metabolic responses of living systems to pathophysiological stimuli or genetic modification, with a focus on elucidating differences in population groups due to genetic modification, disease, and environmental (including nutritional) stress. Metabonomics usually encompasses not only intracellular molecules but also external biofluid components.
This is to inform that due to some circumstances beyond the organizer control, “Euro Global Conference on Proteomics, Genomics and Bioinformatics” (Proteomics 2023) during September 18-20, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at proteomics@magnusconference.com or call +1 (702) 988 2320.
Title : Development of proteomic biomarkers in pancreatic cancer
Ru Chen, Baylor College of Medicine, United States
Title : Nutrition and proteomics: The need for N-of-1 experimental strategies
Jim Kaput, Vydiant, United States
Title : Discovering novel catalytic variants of peroxygenases and antioxidant enzymes in metagenomes and proteomoes from primeval forests in Middle Europe
Marcel Zamocky, Laboratory for Phylogenomic Ecology, Institute of Molecular Biology, Slovak Academy of Sciences, Slovakia (Slovak Republic)
Title : Crispr/Cas9 In Gossypium Hirsutum (Cotton) Coker 312 For Clcud Cotton Leaf Curl Virus Disease Resistance Mediated By Agrobacterium
Tahira Shafique, Fatima Jinnah College of Science and Commerce, Pakistan
Title : Analysis of data on behavioral characteristics of crazy people towards life in Indonesia, the vision of Indonesia being golden in 2045
Arman S Sos M Si, universitas ichsan Gorontalo, Indonesia
Title : The role of Gamma H2AX in apoptosis
Emmy Rogakou, University of Athens, Greece